|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
PT931830E
(pt)
|
1993-02-16 |
2001-08-30 |
Onyx Pharma Inc |
Virus citopaticos para terapia e profilaxia de neoplasia
|
|
US7045347B2
(en)
|
1993-06-24 |
2006-05-16 |
Advec, Inc. |
Helper dependent adenovirus vectors based on integrase family site-specific recombinases
|
|
US20010006629A1
(en)
|
1993-10-25 |
2001-07-05 |
Richard J. Gregory |
Recombinant adenoviral vector and methods of use
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
|
US5962311A
(en)
|
1994-09-08 |
1999-10-05 |
Genvec, Inc. |
Short-shafted adenoviral fiber and its use
|
|
US5965541A
(en)
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
|
FR2726285B1
(fr)
|
1994-10-28 |
1996-11-29 |
Centre Nat Rech Scient |
Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
|
|
CA2206683A1
(en)
|
1994-12-12 |
1996-06-20 |
Genetic Therapy, Inc. |
Improved adenoviral vectors and producer cells
|
|
US6127525A
(en)
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
|
US5770442A
(en)
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
|
US20030026789A1
(en)
|
1995-05-03 |
2003-02-06 |
Richard J. Gregory |
Gene therapy using replication competent targeted adenoviral vectors
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
AUPN477695A0
(en)
|
1995-08-14 |
1995-09-07 |
Commonwealth Scientific And Industrial Research Organisation |
Gene therapy
|
|
US5945335A
(en)
*
|
1995-11-09 |
1999-08-31 |
Avigen, Inc. |
Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences
|
|
US6083720A
(en)
|
1995-11-13 |
2000-07-04 |
Chroboczek; Jadwiga |
Dodecahedral adenoviral protein complex, composition containing same and uses thereof
|
|
IL124654A0
(en)
|
1995-11-28 |
1998-12-06 |
Genvec Inc |
Vectors and method for gene transfer to cells
|
|
US6133243A
(en)
|
1996-02-22 |
2000-10-17 |
Onyx Pharmaceuticals, Inc. |
Liposomal-viral DNA complexes for treating disease
|
|
FR2746110B1
(fr)
|
1996-03-14 |
1998-04-17 |
|
Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants
|
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
IL127692A0
(en)
|
1996-07-01 |
1999-10-28 |
Rhone Poulenc Rorer Sa |
Method for producing recombinant adenovirus
|
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
US5922315A
(en)
|
1997-01-24 |
1999-07-13 |
Genetic Therapy, Inc. |
Adenoviruses having altered hexon proteins
|
|
US6403370B1
(en)
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
|
US20050287120A1
(en)
|
1997-03-21 |
2005-12-29 |
Fisher Paul B |
Cancer - targeted viral vectors
|
|
FR2761689B1
(fr)
|
1997-04-02 |
1999-06-25 |
Transgene Sa |
Fibre adenovirale modifiee et adenovirus cibles
|
|
CA2291323A1
(en)
|
1997-05-28 |
1998-12-03 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
US6200799B1
(en)
*
|
1997-06-03 |
2001-03-13 |
University Of Lausanne |
Somatic gene therapy to suppress secondary cataract formation following eye surgery
|
|
AU8067698A
(en)
|
1997-06-09 |
1998-12-30 |
Genvec, Inc. |
Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
|
|
CN1281512A
(zh)
|
1997-12-12 |
2001-01-24 |
昂尼克斯药物公司 |
p53+肿瘤细胞的选择性杀伤和诊断
|
|
CN1304316A
(zh)
|
1998-02-06 |
2001-07-18 |
亚拉巴马大学伯明翰分校研究基金会 |
在纤维结的hi环中含有异源肽表位的腺病毒载体
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
AU751542B2
(en)
|
1998-02-17 |
2002-08-22 |
Uab Research Foundation, The |
Modified adenovirus containing a fiber replacement protein
|
|
US20050095231A1
(en)
|
1998-02-17 |
2005-05-05 |
Curiel David T. |
Modified adenovirus containing a fiber replacement protein
|
|
AU2796799A
(en)
|
1998-03-03 |
1999-09-20 |
Uab Research Foundation, The |
Amplification of gene transfer and gene therapy by controlled replication
|
|
AU3358999A
(en)
|
1998-03-20 |
1999-10-11 |
Genzyme Corporation |
Chimeric adenoviral vectors for targeted gene delivery
|
|
US6670188B1
(en)
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
|
US7829329B2
(en)
|
1998-04-24 |
2010-11-09 |
Onyx Pharmaceuticals, Inc. |
Adenoviral vectors for treating disease
|
|
DK1199368T3
(da)
|
1998-07-07 |
2004-04-13 |
Transgene Sa |
Anvendelse af adenovirus-E4-læserammer til forbedring af ekspression af et gen af interesse
|
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
|
WO2000012738A1
(en)
|
1998-08-27 |
2000-03-09 |
Aventis Pharma S.A. |
Targeted adenovirus vectors for delivery of heterologous genes
|
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
|
CA2342396A1
(en)
|
1998-09-11 |
2000-03-23 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
US6841540B1
(en)
|
1998-09-29 |
2005-01-11 |
The Uab Research Foundation |
Immunomodulation by genetic modification of dendritic cells and B cells
|
|
PL347898A1
(en)
|
1998-10-15 |
2002-04-22 |
Canji |
Selectively replicating viral vectors
|
|
US20020037274A1
(en)
|
1998-10-26 |
2002-03-28 |
Angelica Williams |
Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
|
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
|
CA2359795A1
(en)
|
1999-01-14 |
2000-07-20 |
Novartis Ag |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
US7157266B2
(en)
|
1999-01-25 |
2007-01-02 |
Brookhaven Science Associates Llc |
Structure of adenovirus bound to cellular receptor car
|
|
US6395875B1
(en)
|
1999-01-25 |
2002-05-28 |
Brookhaven Science Associates Llc |
Recombinant soluble adenovirus receptor
|
|
JP4683727B2
(ja)
|
1999-03-04 |
2011-05-18 |
クルーセル ホランド ベスローテン フェンノートシャップ |
線維芽細胞様またはマクロファージ様細胞の形質導入のための手段と方法
|
|
US6869936B1
(en)
|
1999-03-04 |
2005-03-22 |
Crucell Holland B.V. |
Means and methods for fibroblast-like or macrophage-like cell transduction
|
|
AU767904B2
(en)
|
1999-05-12 |
2003-11-27 |
Uab Research Foundation, The |
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
|
|
US20040175362A1
(en)
|
1999-05-12 |
2004-09-09 |
Curiel David T. |
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
|
|
EP1816204B1
(en)
|
1999-05-17 |
2010-10-20 |
Crucell Holland B.V. |
Recombinant Adenovirus of the Ad26 serotype
|
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
US20050232900A1
(en)
|
1999-05-18 |
2005-10-20 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
EP1593742A3
(en)
|
1999-06-01 |
2006-02-01 |
The University of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection
|
|
US7094398B1
(en)
|
1999-06-01 |
2006-08-22 |
University Of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
|
|
EP1181382B1
(en)
|
1999-06-01 |
2005-03-23 |
The University of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
|
|
DE19929569A1
(de)
|
1999-06-21 |
2000-12-28 |
Holm Per Sonne |
Mittel zur Behandlung maligner Erkrankungen unter Verwendung des Proteins YB-1
|
|
JP2003531568A
(ja)
|
1999-07-06 |
2003-10-28 |
ゴット−エー−ジェーン・エービー |
組換え型アデノウイルス
|
|
US7589069B1
(en)
|
1999-07-12 |
2009-09-15 |
Saint Louis University |
Replication-competent anti-cancer vectors
|
|
WO2001016344A1
(fr)
|
1999-08-27 |
2001-03-08 |
Transgene S.A. |
Fibre adenovirale modifiee et utilisations
|
|
AU1070901A
(en)
|
1999-09-23 |
2001-04-24 |
Genvec, Inc. |
Method of treating cells of the prostate prophylactically or therapeutically
|
|
CA2384827A1
(en)
|
1999-09-24 |
2001-03-29 |
The Uab Research Foundation |
Capsid-modified recombinant adenovirus and methods of use
|
|
AU1190901A
(en)
|
1999-09-30 |
2001-04-30 |
Trustees Of The University Of Pennsylvania, The |
Replication selective adenoviruses for use in cancer therapy
|
|
US6635476B1
(en)
|
1999-10-15 |
2003-10-21 |
Canji, Inc. |
Targeted vectors
|
|
MXPA02004736A
(es)
|
1999-11-12 |
2003-01-28 |
Oncolytics Biotech Inc |
Virus para el tratamiento de trastornos proliferativos celulares.
|
|
US7001596B1
(en)
|
1999-11-15 |
2006-02-21 |
Onyx Pharmaceuticals, Inc. |
Oncolytic adenovirus
|
|
US6867022B1
(en)
|
2000-01-21 |
2005-03-15 |
Regents Of The University Of Michigan |
Replication deficient adenovirus vectors and methods of making and using them
|
|
AU2001234981A1
(en)
|
2000-02-09 |
2001-08-20 |
Genvec, Inc. |
Adenoviral capsid containing chimeric protein ix
|
|
US6911200B2
(en)
|
2000-03-24 |
2005-06-28 |
Cell Genesys, Inc. |
Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
|
|
DE60136268D1
(de)
|
2000-03-24 |
2008-12-04 |
Cell Genesys Inc |
Interne ribosomenzugangsstelle-enthaltende zell-spezifische adenovirale vektoren
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
US20030082146A1
(en)
|
2000-04-26 |
2003-05-01 |
Van Es Helmuth H. G. |
Adenovirus vectors with knobless fibers, and their uses
|
|
EP1280929A2
(en)
|
2000-05-01 |
2003-02-05 |
Novartis AG |
Vectors for ocular transduction and use thereof for genetic therapy
|
|
US7332337B2
(en)
|
2000-05-16 |
2008-02-19 |
Galapagos Nv |
Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells
|
|
EP1157999A1
(en)
|
2000-05-24 |
2001-11-28 |
Introgene B.V. |
Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
|
|
EP1284294A4
(en)
|
2000-05-26 |
2004-10-13 |
Sumitomo Pharma |
RECOMBINANT ADENOVIRUS WITH REDUCED SIDE EFFECTS (12/05/01)
|
|
EP1301612A2
(en)
|
2000-05-31 |
2003-04-16 |
Genvec, Inc. |
Method and composition for targeting an adenoviral vector
|
|
AU6368901A
(en)
|
2000-05-31 |
2001-12-11 |
Univ Saskatchewan |
Modified bovine adenovirus having altered tropism
|
|
US7754201B2
(en)
|
2000-06-02 |
2010-07-13 |
GenPhar, Inc |
Method of vaccination through serotype rotation
|
|
EP1167533A1
(en)
|
2000-06-23 |
2002-01-02 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Methods and means for the complementation of viral protein expression in stable cell lines
|
|
US6579522B1
(en)
|
2000-06-27 |
2003-06-17 |
Genvec, Inc. |
Replication deficient adenoviral TNF vector
|
|
US7022496B2
(en)
|
2000-07-14 |
2006-04-04 |
The Johns Hopkins University |
Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA
|
|
US20020106382A1
(en)
|
2000-07-14 |
2002-08-08 |
Young Charles S.H. |
Modified adenovirus and uses thereof
|
|
GB0017720D0
(en)
|
2000-07-19 |
2000-09-06 |
Got A Gene Ab |
Modified virus
|
|
WO2002012523A2
(en)
|
2000-08-10 |
2002-02-14 |
Crucell Holland B.V. |
Transduction of chondrocytes using adenoviral vectors
|
|
US7235233B2
(en)
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
|
WO2002046372A1
(en)
|
2000-12-08 |
2002-06-13 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
US20030095989A1
(en)
|
2000-12-18 |
2003-05-22 |
Irving John M. |
Chimeric cytolytic viruses for cancer treatment
|
|
US6635466B2
(en)
|
2001-01-09 |
2003-10-21 |
University Of Iowa Research Foundation |
Adenovirus serotype 30 (Ad30)
|
|
WO2002064746A2
(en)
|
2001-02-14 |
2002-08-22 |
Uab Research Foundation |
Combined transductional and transcriptional targeting system for improved gene delivery
|
|
IL152420A0
(en)
|
2001-02-23 |
2003-05-29 |
Novartis Ag |
Novel oncolytic adenoviral vectors
|
|
JP2005525779A
(ja)
|
2001-04-02 |
2005-09-02 |
バイエル アクチェンゲゼルシャフト |
核酸構築物のトランスフェクションによって、身体サンプルから細胞を特異的に検出、単離および特徴付けするための方法
|
|
US20030138405A1
(en)
|
2001-04-17 |
2003-07-24 |
Juan Fueyo |
Conditionally replicative adenovirus to target the Rb and Rb-related pathways
|
|
US20030219899A1
(en)
|
2001-04-17 |
2003-11-27 |
Nikolay Korokhov |
Mosaic adenoviral vectors
|
|
US20020151069A1
(en)
|
2001-04-17 |
2002-10-17 |
Nikolay Korokhov |
Mosaic adenoviral vectors
|
|
ES2375557T3
(es)
|
2001-06-22 |
2012-03-02 |
The Trustees Of The University Of Pennsylvania |
Adenovirus recombinantes que comprenden prote�?nas de adenovirus de simios y usos de los mismos.
|
|
US6844192B2
(en)
*
|
2001-06-29 |
2005-01-18 |
Wake Forest University |
Adenovirus E4 protein variants for virus production
|
|
US6905678B2
(en)
|
2001-07-07 |
2005-06-14 |
Crucell Holland B.V. |
Gene delivery vectors with cell type specificity for mesenchymal stem cells
|
|
JP2004536607A
(ja)
|
2001-07-23 |
2004-12-09 |
オニックス ファーマシューティカルズ，インコーポレイティド |
標的化されたヒト癌細胞において選択的に複製するウイルス変異体
|
|
CA2460157A1
(en)
|
2001-09-18 |
2003-03-27 |
Clontech Laboratories, Inc. |
Site-specific recombinase based method for producing adenoviral vectors
|
|
US7569217B2
(en)
*
|
2001-09-24 |
2009-08-04 |
University Of Saskatchewan |
Porcine adenovirus E1 and E4 regions
|
|
AU2002343901A1
(en)
|
2001-09-29 |
2003-04-14 |
Kim, Joo-Hang |
Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
|
|
KR100987360B1
(ko)
|
2001-11-21 |
2010-10-12 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
원숭이 아데노바이러스 핵산과 아미노산 서열, 이를함유하는 벡터 및 사용방법
|
|
CN100475966C
(zh)
|
2001-11-23 |
2009-04-08 |
上海三维生物技术有限公司 |
具有肿瘤细胞特异性感染和转基因表达能力的新型腺病毒
|
|
EP1327688A1
(en)
|
2002-01-14 |
2003-07-16 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Adenoviruses with enhanced lytic potency
|
|
WO2003062400A2
(en)
|
2002-01-24 |
2003-07-31 |
The Scripps Research Institute |
Fiber shaft modifications for efficient targeting
|
|
AU2003206815A2
(en)
|
2002-02-01 |
2003-09-02 |
Transgene S.A. |
Adenoviral vectors for modulating the cellular activities associated with PODs
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
US20040005710A1
(en)
|
2002-03-09 |
2004-01-08 |
Ho-Sun Son |
Method for producing recombinant viruses using site-specific recombination
|
|
US7344711B2
(en)
|
2002-03-26 |
2008-03-18 |
Oncolytics Biotech Inc. |
Use of adenoviruses mutated in the VA genes for cancer treatment
|
|
ES2335657T3
(es)
*
|
2002-04-25 |
2010-03-31 |
Crucell Holland B.V. |
Medios y metodos para la produccion de vectores de adenovirus.
|
|
WO2003092579A2
(en)
|
2002-04-29 |
2003-11-13 |
Hadasit Medical Research Services And Development Company Ltd. |
Compositions and methods for treating cancer with an oncolytic viral agent
|
|
US7094399B2
(en)
|
2002-05-08 |
2006-08-22 |
Intronn, Inc. |
Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses
|
|
CN1655827B
(zh)
|
2002-05-27 |
2010-06-23 |
佩尔·松内·霍尔姆 |
腺病毒和编码其的核酸的新应用
|
|
CA2491805A1
(en)
|
2002-07-10 |
2004-01-22 |
Transgene S.A. |
Modified adenoviral fiber with ablated binding to cellular receptors
|
|
WO2004009768A2
(en)
|
2002-07-18 |
2004-01-29 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
|
US7364727B2
(en)
|
2002-07-22 |
2008-04-29 |
Cell Genesys, Inc. |
Metastatic colon cancer specific promoter and uses thereof
|
|
EP1539937A4
(en)
*
|
2002-08-22 |
2006-07-26 |
Merck & Co Inc |
METHOD FOR THE REPRODUCTION OF ADENOVIRUS AND PRODUCT VIRUS THEREWITH
|
|
US20060099709A1
(en)
|
2002-10-01 |
2006-05-11 |
Chuan-Yuan Li |
Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
|
|
EP1413586A1
(en)
|
2002-10-21 |
2004-04-28 |
Centre National De La Recherche Scientifique (Cnrs) |
Regulation of the Cre recombinase using a dissociation/re-association system of said recombinase
|
|
US20040102382A1
(en)
|
2002-11-27 |
2004-05-27 |
Transgene, S.A. |
Targeting peptides
|
|
WO2004083418A1
(en)
|
2003-03-17 |
2004-09-30 |
Merck & Co., Inc. |
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
|
|
US20040191761A1
(en)
|
2003-03-27 |
2004-09-30 |
Routes John M. |
Modified adenoviral E1A constructs and methods of use thereof
|
|
US20040213764A1
(en)
|
2003-03-28 |
2004-10-28 |
William Wold |
Adenovirus replication-competent vectors expressing trail
|
|
WO2004099422A2
(en)
|
2003-03-28 |
2004-11-18 |
The Scripps Research Institute |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
|
US20040191222A1
(en)
|
2003-03-28 |
2004-09-30 |
Emini Emilio A. |
Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby
|
|
US20050095705A1
(en)
|
2003-04-15 |
2005-05-05 |
Michael Kadan |
Method for production of oncolytic adenoviruses
|
|
WO2005027711A2
(en)
|
2003-05-01 |
2005-03-31 |
University Of Washington |
Capsid-modified adenovirus vectors and methods of using the same
|
|
US7611868B2
(en)
|
2003-05-14 |
2009-11-03 |
Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Recombinant modified adenovirus fiber protein
|
|
US20050079158A1
(en)
|
2003-06-05 |
2005-04-14 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
|
|
WO2004108755A2
(en)
|
2003-06-10 |
2004-12-16 |
University Of Saskatchewan |
Chimeric adenovirus capsid proteins
|
|
JP2007531507A
(ja)
|
2003-06-11 |
2007-11-08 |
ザ スクリップス リサーチ インスティテュート |
効率的な受容体結合のための修飾型線維タンパク質
|
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
US7491508B2
(en)
|
2003-06-20 |
2009-02-17 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
CA2527369A1
(en)
|
2003-07-18 |
2005-02-03 |
Onyx Pharmaceuticals, Inc. |
Subgroup b adenoviral vectors for treating disease
|
|
ES2391975T3
(es)
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
|
US20050186178A1
(en)
|
2003-08-28 |
2005-08-25 |
Ennist David L. |
Oncolytic adenoviral vectors encoding GM-CSF
|
|
AU2003265873A1
(en)
|
2003-08-28 |
2005-04-14 |
Cell Genesys, Inc. |
Oncolytic adenoviral vectors encoding gm-csf
|
|
WO2005023848A2
(en)
|
2003-09-09 |
2005-03-17 |
Gardner, Rebecca, Katherine |
Adenoviral epitopes
|
|
US7482156B2
(en)
|
2003-10-15 |
2009-01-27 |
Cell Genesys, Inc. |
Hepatocellular carcinoma specific promoter and uses thereof
|
|
WO2005051430A1
(de)
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
Neue verwendung von adenoviren und dafür codierenden nukleinsäuren
|
|
WO2005048950A2
(en)
|
2003-11-17 |
2005-06-02 |
Biomune, Inc. |
Tumor and infectious disease therapeutic compositions
|
|
ATE546531T1
(de)
|
2003-12-31 |
2012-03-15 |
Kalobios Inc |
Transaktivierungssystem für säugerzellen
|
|
WO2005075506A1
(en)
|
2004-01-09 |
2005-08-18 |
The Scripps Research Institute |
Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors
|
|
ES2871907T3
(es)
|
2004-01-23 |
2021-11-02 |
Msd Italia Srl |
Portadores de vacuna de adenovirus de chimpancé
|
|
US20050201936A1
(en)
|
2004-02-12 |
2005-09-15 |
Wold William S.M. |
Models for viral-based cancer therapy
|
|
WO2005086922A2
(en)
|
2004-03-10 |
2005-09-22 |
Board Of Regents, University Of Texas System |
Oncolytic adenovirus armed with therapeutic genes
|
|
US7473418B2
(en)
|
2004-03-25 |
2009-01-06 |
Cell Genesys, Inc. |
Pan cancer oncolytic vectors and methods of use thereof
|
|
EP1729817B1
(en)
|
2004-03-30 |
2014-03-05 |
Industry-Academic Cooperation Foundation |
Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin
|
|
WO2005107474A2
(en)
|
2004-04-30 |
2005-11-17 |
Introgen Therapeutics, Inc. |
Oncolytic adenovirus armed with therapeutic genes
|
|
WO2005106046A1
(en)
|
2004-05-03 |
2005-11-10 |
Stefan Kochanek |
Modified viral vector particles
|
|
GB0411428D0
(en)
|
2004-05-21 |
2004-06-23 |
Got A Gene Ab |
Vectors
|
|
WO2005118825A2
(en)
|
2004-05-26 |
2005-12-15 |
Schering Aktiengesellschaft |
Chimeric adenoviruses for use in cancer treatment
|
|
US20050271622A1
(en)
|
2004-06-03 |
2005-12-08 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
|
|
WO2005117993A2
(en)
|
2004-06-04 |
2005-12-15 |
Genvec, Inc. |
Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer
|
|
CN100361710C
(zh)
|
2004-06-07 |
2008-01-16 |
成都康弘生物科技有限公司 |
肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用
|
|
US20060292682A1
(en)
|
2004-07-22 |
2006-12-28 |
Hawkins Lynda K |
Addition of transgenes into adenoviral vectors
|
|
GB0416487D0
(en)
|
2004-07-23 |
2004-08-25 |
Isis Innovation |
Modified virus
|
|
US7776322B2
(en)
|
2004-08-16 |
2010-08-17 |
Stefan Kochanek |
Modified viral vector particles
|
|
WO2006039045A2
(en)
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
|
US7943373B2
(en)
|
2004-09-29 |
2011-05-17 |
Oncolys Biopharma, Inc. |
Telomelysin/GFP-expressing recombinant virus
|
|
US7741099B2
(en)
|
2004-10-13 |
2010-06-22 |
Beth Israel Deaconess Medical Center Inc. |
Adenoviral vectors and uses thereof
|
|
MX2007004968A
(es)
|
2004-10-25 |
2007-06-15 |
Novartis Ag |
Polinucleotidos y polipeptidos torc, y metodos de uso.
|
|
IL166049A0
(en)
|
2004-12-30 |
2006-01-15 |
Gavish Galilee Bio Appl Ltd |
Method for obtaining modified proteins and viruseswith intact native binding
|
|
EP1830864A2
(de)
|
2004-12-31 |
2007-09-12 |
Per Sonne Holm |
E1 -minus adenoviren und deren verwendung
|
|
AU2006203736B2
(en)
|
2004-12-31 |
2012-03-29 |
Per Sonne Holm |
Method for reversing multiple resistance in animal cells
|
|
WO2006086357A2
(en)
|
2005-02-10 |
2006-08-17 |
Merck & Co., Inc. |
Adenovirus serotype 36 vectors, nucleic acid and viruses produced thereby
|
|
JP2008538894A
(ja)
|
2005-02-11 |
2008-11-13 |
メルク エンド カムパニー インコーポレーテッド |
アデノウイルス血清型２６ベクター、核酸およびそれにより製造されたウイルス
|
|
KR100747646B1
(ko)
|
2005-02-25 |
2007-08-08 |
연세대학교 산학협력단 |
데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물
|
|
WO2006119449A2
(en)
|
2005-05-04 |
2006-11-09 |
Vectorlogics, Inc. |
Modified adenovirus containing a stabilized antibody
|
|
WO2007050128A2
(en)
|
2005-05-31 |
2007-05-03 |
Vectorlogics, Inc. |
Shielded adenoviral vectors and methods of use
|
|
EP1893636A2
(en)
|
2005-06-17 |
2008-03-05 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hepatitis c virus nucleic acid vaccine
|
|
WO2007027860A2
(en)
|
2005-08-31 |
2007-03-08 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
KR100723009B1
(ko)
|
2005-11-30 |
2007-05-29 |
한국원자력연구원 |
인간 ｐ３１ 유전자를 함유하는 악성 종양 치료용 약학적조성물
|
|
ES2304281B1
(es)
|
2006-02-01 |
2009-08-12 |
Dnatrix Inc. |
Adenovirus oncoliticos para el tratamiento del cancer.
|
|
WO2007094653A1
(en)
|
2006-02-13 |
2007-08-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
|
|
US20070292396A1
(en)
|
2006-03-02 |
2007-12-20 |
Juan Fueyo |
Combination therapy with oncolytic adenovirus
|
|
US20070292954A1
(en)
|
2006-04-21 |
2007-12-20 |
The Brigham And Women's Hospital, Inc. |
Generation of recombinant DNA by sequence-and ligation-independent cloning
|
|
US20090074810A1
(en)
|
2006-04-28 |
2009-03-19 |
The Trustees Of The University Of Pennsylvania |
Modified Adenovirus Hexon Protein and Uses Thereof
|
|
US20080242608A1
(en)
|
2006-06-02 |
2008-10-02 |
Azad Bonni |
Methods and compositions for treating and preventing neurologic disorders
|
|
EP2041291A1
(en)
|
2006-06-19 |
2009-04-01 |
Institut Gustave Roussy |
Inhibition of the liver tropism of adenoviral vectors
|
|
JP2008048621A
(ja)
|
2006-08-22 |
2008-03-06 |
Chiba Prefecture |
キメラ型アデノウイルスとその作製方法並びにそれを用いた医薬
|
|
GR20060100496A
(el)
|
2006-09-01 |
2008-04-15 |
Παρθενιος Μπουλικας |
ΛΙΠΟΣΩΜΑΤΙΚΑ ΕΓΚΑΨΥΛΙΩΜΕΝΟΙ ΦΟΡΕΙΣ-ΥΒΡΙΔΙΟΥ ΑΔΕΝΟΙΟΥ - ΙΟΥ SEMLIKI FOREST (SFV), ΠΟΥ ΦΕΡΕΙ ΚΑΤΑΣΚΕΥΑΣΜΑΤΑ RNAi ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΑ ΓΟΝΙΔΙΑ ΠΟΥ ΧΡΗΣΙΜΟΠΟΙΟΥΝΤΑΙ ΕΝΑΝΤΙΟΝ ΣΤΟΧΩΝ ΚΑΡΚΙΝΟΥ ΚΑΙ ΑΛΛΩΝ ΑΣΘΕΝΕΙΩΝ
|
|
US20100098668A1
(en)
|
2006-09-29 |
2010-04-22 |
Northshore University Health System |
Oncolytic Adenoviruses and Uses Thereof
|
|
WO2008140474A1
(en)
|
2006-10-26 |
2008-11-20 |
Johns Hopkins University |
Recombinant adenovirus vaccines
|
|
WO2008065054A1
(en)
|
2006-11-28 |
2008-06-05 |
Nerviano Medical Sciences S.R.L. |
Tricyclic indoles and (4,5-dihydro) indoles
|
|
WO2008095168A2
(en)
|
2007-02-01 |
2008-08-07 |
University Of Chicago |
Compositions and methods related to a recombinant adenoviral vector that targets il 13 receptors
|
|
CN101702918B
(zh)
|
2007-03-14 |
2013-03-27 |
卡塔拉肿瘤研究所 |
具有e3-19k蛋白的内质网滞留结构域内突变的腺病毒及其在癌症治疗中的应用
|
|
US20090081639A1
(en)
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
|
WO2009065800A1
(en)
|
2007-11-20 |
2009-05-28 |
Crucell Holland B.V. |
Recombinant human adenoviruses for eliciting mucosal immune responses
|
|
CA2706257C
(en)
|
2007-11-28 |
2017-06-06 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily b adenovirus sadv-28, -27, -29, -32, -33 and -35 and uses thereof
|
|
CN101883858B
(zh)
|
2007-11-28 |
2015-07-22 |
宾夕法尼亚大学托管会 |
猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用
|
|
EP2220217A2
(en)
|
2007-11-28 |
2010-08-25 |
The Trustees of the University of Pennsylvania |
Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof
|
|
EP2252316A2
(en)
|
2008-02-07 |
2010-11-24 |
Andrew Baker |
Modulation of adenoviral tropism
|
|
CN102016011B
(zh)
|
2008-03-04 |
2013-12-11 |
宾夕法尼亚大学托管会 |
猿猴腺病毒sadv-36、-42.1、-42.2和-44及其应用
|
|
WO2009117656A2
(en)
|
2008-03-21 |
2009-09-24 |
Vectorlogics,Inc. |
Capsid-incorporated antigen for novel adenovirus vaccine
|
|
WO2009149252A1
(en)
|
2008-06-04 |
2009-12-10 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
CN102066365A
(zh)
|
2008-06-19 |
2011-05-18 |
米伦纽姆医药公司 |
噻吩或噻唑衍生物和其作为pi3k抑制剂的用途
|
|
KR101034811B1
(ko)
|
2008-08-25 |
2011-05-16 |
단국대학교 산학협력단 |
조직 특이적 프로모터와 암 특이 유전자를 타겟팅하는트랜스-스플라이싱 라이보자임을 포함하는 재조합아데노바이러스 및 이의 용도
|
|
EP2352516A2
(en)
|
2008-09-26 |
2011-08-10 |
Auburn University |
Immunization of avians by mucosal administration of non-replicating vectored vaccines
|
|
DK2350269T3
(en)
|
2008-10-31 |
2015-12-07 |
Univ Pennsylvania |
ABE ADENOVIRUS WITH SADV-46 HEXONCAPSIDE PROTEINS AND APPLICATIONS THEREOF
|
|
US9345787B2
(en)
|
2008-12-22 |
2016-05-24 |
Targovax Oy |
Adenoviral vectors and methods and uses related thereto
|
|
ES2612889T3
(es)
|
2008-12-22 |
2017-05-19 |
Targovax Oy |
Vectores adenovíricos oncolíticos y procedimientos y utilizaciones relacionados con los mismos
|
|
MX2011007980A
(es)
|
2009-02-02 |
2011-08-17 |
Okairos Ag |
Secuencias de acido nucleico y aminoacido de adenovirus de simio, vectores que contienen los mismos y usos de las mismas.
|
|
PT2403951E
(pt)
|
2009-03-02 |
2016-01-29 |
Univ California |
Mutantes de adenovírus e1a e e1b de tumores
|
|
ES2385251B1
(es)
|
2009-05-06 |
2013-05-06 |
Fundació Privada Institut D'investigació Biomèdica De Bellvitge |
Adenovirus oncolíticos para el tratamiento del cáncer.
|
|
CA2762203A1
(en)
|
2009-05-29 |
2010-12-02 |
Soumitra Roy |
Simian adenovirus 41 and uses thereof
|
|
US8865182B2
(en)
|
2009-07-31 |
2014-10-21 |
Paxvax, Inc. |
Adenoviral-based vectors
|
|
US9555089B2
(en)
|
2009-08-18 |
2017-01-31 |
The Rockefeller University |
Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
|
|
WO2011022002A1
(en)
|
2009-08-18 |
2011-02-24 |
The Rockefeller University |
Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
|
|
KR101248912B1
(ko)
|
2009-12-31 |
2013-03-29 |
한양대학교 산학협력단 |
항혈관신생 활성을 가지는 재조합 아데노바이러스
|
|
WO2011101869A1
(en)
|
2010-02-22 |
2011-08-25 |
Transgene Biotek Ltd. |
Adeno-associated virus 2/8 - micro rna-101 therapy for liver cancer
|
|
CN102191245B
(zh)
|
2010-03-15 |
2013-11-13 |
浙江东方基因生物制品有限公司 |
应用肿瘤特异性启动子表达报告基因来检测循环血中肿瘤细胞的方法和试剂
|
|
CN102892429B
(zh)
|
2010-03-17 |
2016-08-31 |
康奈尔大学 |
基于被破坏的腺病毒的抗滥用药物疫苗
|
|
CN102844329B
(zh)
|
2010-04-14 |
2016-01-20 |
财团法人牧岩生命工学研究所 |
分离自猿腺病毒血清型19的六邻体、其高变区和使用其的嵌合型腺病毒
|
|
WO2011133040A2
(en)
|
2010-04-23 |
2011-10-27 |
Orca Therapeutics B.V. |
Replication-competent adenoviruses
|
|
KR101497035B1
(ko)
|
2010-04-26 |
2015-02-27 |
주식회사 녹십자 |
종양 특이적 프로모터 및 이를 포함하는 종양살상 바이러스 벡터
|
|
KR20180122043A
(ko)
|
2010-06-10 |
2018-11-09 |
유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 |
데스모글레인 2(디에스쥐2)와 아데노바이러스의 상호작용을 위한 방법 및 시스템
|
|
WO2012003287A2
(en)
|
2010-06-30 |
2012-01-05 |
The Johns Hopkins University |
Compositions and methods for detecting and quantifying circulating tumor cells ctcs
|
|
BR112013003579A2
(pt)
|
2010-08-16 |
2016-06-07 |
Salk Inst For Biological Studi |
adenovírus, células, e, métodos para tratar câncer
|
|
EP2606127B1
(en)
|
2010-08-16 |
2019-03-20 |
Salk Institute For Biological Studies |
Adenoviral assembly method
|
|
WO2012022496A2
(en)
|
2010-08-19 |
2012-02-23 |
Per Sonne Holm |
Method for killing tumor stem cells
|
|
EP2619312A1
(en)
|
2010-09-24 |
2013-07-31 |
Oncos Therapeutics Oy |
Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
|
|
EP2619224A1
(en)
|
2010-09-24 |
2013-07-31 |
Oncos Therapeutics Oy |
Oncolytic adenoviral vectors and methods and uses related thereto
|
|
EP3075860A1
(en)
|
2010-11-23 |
2016-10-05 |
The Trustees of the University of Pennsylvania |
Subfamily e simian adenovirus a1295 and uses thereof
|
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
|
CN102174479B
(zh)
|
2011-03-02 |
2013-04-03 |
北京锤特生物科技有限公司 |
靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用
|
|
JP5975352B2
(ja)
|
2011-03-25 |
2016-08-23 |
国立大学法人 鹿児島大学 |
癌幹細胞を標的とするウイルスベクター
|
|
US20140341857A1
(en)
|
2011-05-16 |
2014-11-20 |
Institut Gustave Roussy |
Combination of oncolytic adenoviruses with histone deacetylase inhibitors
|
|
WO2012162342A2
(en)
|
2011-05-23 |
2012-11-29 |
The Wistar Institute Of Anatomy And Biology |
Influenza vaccines containing modified adenovirus vectors
|
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
|
CN102260712B
(zh)
|
2011-05-31 |
2013-10-02 |
北京锤特生物科技有限公司 |
溶肿瘤能力增强的B型人腺病毒Ad11突变体的构建和应用
|
|
JP5971599B2
(ja)
|
2011-08-23 |
2016-08-17 |
国立研究開発法人医薬基盤・健康・栄養研究所 |
制限増殖型アデノウイルス
|
|
WO2013036791A2
(en)
|
2011-09-09 |
2013-03-14 |
Beth Israel Deaconess Medical Center, Inc. |
Modified adenoviral vectors and methods of treatment using same
|
|
JP6757120B2
(ja)
|
2011-10-05 |
2020-09-16 |
ジェンヴェック エルエルシー |
アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
|
|
FI123955B
(en)
|
2011-11-25 |
2014-01-15 |
Oncos Therapeutics Ltd |
Oncolytic adenovirus
|
|
US9267153B2
(en)
|
2011-12-15 |
2016-02-23 |
Washington University |
Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
|
|
SG10201913795TA
(en)
|
2012-02-02 |
2020-03-30 |
Univ Texas |
Adenoviruses expressing heterologous tumor-associated antigens
|
|
CA2864956C
(en)
|
2012-03-12 |
2021-11-09 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
CA2867129C
(en)
|
2012-03-13 |
2023-11-21 |
Salk Institute For Biological Studies |
Selective cell targeting using adenovirus and chemical dimers
|
|
IN2014DN06898A
(enExample)
|
2012-03-14 |
2015-05-15 |
Salk Inst For Biological Studi |
|
|
US9017672B2
(en)
|
2012-05-11 |
2015-04-28 |
Immunicum Aktiebolag |
Hexon Tat-PTD modified adenovirus and uses thereof
|
|
JP6293738B2
(ja)
|
2012-05-18 |
2018-03-14 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
亜科ｅサルアデノウイルスａ１３０２、ａ１３２０、ａ１３３１及びａ１３３７ならびにそれらの使用
|
|
US9476061B2
(en)
|
2012-05-24 |
2016-10-25 |
Janssen Vaccines & Prevention B.V. |
Adenoviral vectors for transduction of vascular tissue
|
|
EP2855669B1
(en)
|
2012-05-29 |
2018-10-10 |
GenVec, Inc. |
Modified serotype 28 adenoviral vectors
|
|
AU2013203696A1
(en)
|
2012-06-25 |
2014-01-16 |
University Of Canberra |
Recombinant Viral Vectors and Uses Therefor
|
|
AU2013323775B2
(en)
|
2012-09-25 |
2018-10-18 |
University Of Washington Through Its Center For Commercialization |
Desmoglein 2 (DSG2) binding proteins and uses therefor
|
|
KR101429696B1
(ko)
|
2012-11-21 |
2014-08-13 |
국립암센터 |
안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도
|
|
EP2961417A1
(en)
|
2013-02-28 |
2016-01-06 |
PsiOxus Therapeutics Limited |
A process for the production of adenovirus
|
|
WO2014160475A1
(en)
|
2013-03-13 |
2014-10-02 |
Aboody Karen S |
Tropic cell based virotherapy for the treatment of cancer
|
|
CA2903582C
(en)
|
2013-03-14 |
2021-06-08 |
Salk Institute For Biological Studies |
Oncolytic adenovirus compositions
|
|
WO2014170389A1
(en)
|
2013-04-18 |
2014-10-23 |
Tilt Biotherapeutics Oy |
Enhanced adoptive cell therapy
|
|
ES2878549T3
(es)
|
2013-06-18 |
2021-11-19 |
Dnatrix Inc |
Adenovirus oncolítico para su uso en el tratamiento del cáncer cerebral
|
|
JP2016538327A
(ja)
|
2013-09-24 |
2016-12-08 |
ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション |
デスモグレイン２（ｄｓｇ２）結合タンパク質およびその使用
|
|
CA2931322A1
(en)
|
2013-11-22 |
2015-05-28 |
Dnatrix, Inc. |
Adenovirus expressing immune cell stimulatory receptor agonist(s)
|
|
GB201415579D0
(en)
|
2014-09-03 |
2014-10-15 |
Psioxus Therapeutics Ltd |
A process
|
|
GB201406608D0
(en)
|
2014-04-12 |
2014-05-28 |
Psioxus Therapeutics Ltd |
Virus
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
NZ726112A
(en)
|
2014-05-19 |
2021-07-30 |
Valo Therapeutics Oy |
Coated adenoviruses for immunotherapy
|
|
KR102365331B1
(ko)
|
2014-05-28 |
2022-02-22 |
고꾸리츠 다이가꾸 호우징 오까야마 다이가꾸 |
Reic 유전자를 발현하는 제한 증식형 아데노바이러스
|
|
DK3198009T3
(da)
|
2014-09-24 |
2021-11-22 |
Salk Inst For Biological Studi |
Onkolytiske tumorvira og anvendelsesfremgangsmåder
|
|
WO2016106178A1
(en)
|
2014-12-24 |
2016-06-30 |
The Uab Research Foundation, Inc. |
Multitargeting onocolytic adenovirus, methods of use, and methods of making
|
|
EP3247807B1
(en)
|
2015-01-20 |
2020-12-16 |
Adcure Biotechnologies, LLC. |
Detargeted adenovirus variants and related methods
|
|
WO2016141073A1
(en)
|
2015-03-02 |
2016-09-09 |
Washington University |
Induction of pacemaker-like cells from cardiomyocytes
|
|
CN107406859A
(zh)
|
2015-03-17 |
2017-11-28 |
倾斜生物医疗公司 |
编码双特异性抗体的溶瘤腺病毒及与其相关的方法和用途
|
|
EP3072900A1
(en)
|
2015-03-27 |
2016-09-28 |
Medizinische Hochschule Hannover |
Anti-tumour medicament based on adenovirus
|
|
GB201505860D0
(en)
|
2015-04-07 |
2015-05-20 |
Agalimmune Ltd |
Therapeutic compositions and methods of use for treating cancer
|
|
GB201513176D0
(en)
|
2015-07-27 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel methods for inducing an immune response
|
|
US20180369417A1
(en)
|
2015-09-01 |
2018-12-27 |
Industry-University Coorperation Foundation Hanyang University |
Antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegf
|
|
ES2837400T3
(es)
|
2015-10-05 |
2021-06-30 |
Salk Inst For Biological Studi |
Adenovirus sintético con tropismo para los tejidos dañados para su uso en la promoción de la reparación de heridas y regeneración tisular
|
|
ES2994611T3
(en)
|
2015-10-19 |
2025-01-27 |
Cg Oncology Inc |
Methods of treating solid or lymphatic tumors by combination therapy
|
|
WO2017075395A1
(en)
|
2015-10-28 |
2017-05-04 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Tumor-specific adenovirus vectors and therapeutic uses
|
|
JP7015551B2
(ja)
|
2016-02-23 |
2022-02-15 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
|
|
WO2017147265A1
(en)
|
2016-02-23 |
2017-08-31 |
Salk Institute For Biological Studies |
High throughput assay for measuring adenovirus replication kinetics
|
|
WO2017156349A1
(en)
|
2016-03-10 |
2017-09-14 |
Cold Genesys, Inc. |
Methods of treating solid or lymphatic tumors by combination therapy
|
|
US20170314044A1
(en)
|
2016-05-02 |
2017-11-02 |
Regents Of The University Of Minnesota |
Adenovirus constructs and methods
|
|
US20190201551A1
(en)
|
2016-05-23 |
2019-07-04 |
Washington University |
Pulmonary targeted cas9/crispr for in vivo editing of disease genes
|
|
WO2017205875A1
(en)
|
2016-05-27 |
2017-11-30 |
Dnatrix, Inc. |
Adenovirus and immunomodulator combination therapy
|
|
GB2549809C
(en)
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
|
US11155832B2
(en)
|
2016-09-30 |
2021-10-26 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into T cells
|
|
FI20165814A
(fi)
|
2016-10-27 |
2018-04-28 |
Tilt Biotherapeutics Oy |
Interleukiini 8 (il-8) prognostisena ja ennustavana biomarkkerina ja koostumukset ja vektorit käytettäväksi onkolyyttisessa immunoterapiassa
|
|
WO2018085461A1
(en)
|
2016-11-01 |
2018-05-11 |
Dnatrix, Inc. |
Combination therapy for treatment of brain cancers
|
|
WO2018083257A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding transgenes
|
|
WO2018083258A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding at least three transgenes
|
|
WO2018083259A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding transgenes
|
|
EP3512533B9
(en)
|
2016-11-17 |
2021-05-19 |
VCN Biosciences SL |
Oncolytic viral vectors for use in the treatment of retinoblastoma
|
|
ES2959811T3
(es)
|
2016-12-09 |
2024-02-28 |
Glaxosmithkline Biologicals Sa |
Construcciones de adenovirus de chimpancé con antígenos de Lyssavirus
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CA3045892A1
(en)
|
2016-12-12 |
2018-06-21 |
Salk Institute For Biological Studies |
Tumor-targeting synthetic adenoviruses and uses thereof
|
|
US10232053B2
(en)
|
2016-12-30 |
2019-03-19 |
Trieza Therapeutics, Inc. |
Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
|
|
WO2018125970A1
(en)
|
2016-12-30 |
2018-07-05 |
Salk Institute For Biological Studies |
Synthetic adenoviruses targeting bone tissue and uses thereof
|
|
SG11201906973TA
(en)
|
2017-01-30 |
2019-08-27 |
Epicentrx Inc |
Multiple transgene recombinant adenovirus
|
|
US20190352669A1
(en)
|
2017-01-30 |
2019-11-21 |
Epicentrx, Inc. |
Tumor selective tata-box and caat-box mutants
|
|
EP3610003A4
(en)
|
2017-04-10 |
2021-01-06 |
EpicentRx, Inc. |
RECOMBINANT VIRUS PRODUCTION PROCESS
|
|
EA201990822A1
(ru)
|
2017-04-12 |
2020-01-09 |
Эписентарикс, Инк. |
Иммуномодулирующие слитые белки
|
|
CA3060573A1
(en)
|
2017-04-21 |
2018-10-25 |
Baylor College Of Medicine |
Oncolytic virotherapy and immunotherapy
|
|
WO2018201017A1
(en)
|
2017-04-27 |
2018-11-01 |
Washington University |
Dendritic cell targeted adenovirus for vaccination
|
|
WO2018204677A1
(en)
|
2017-05-04 |
2018-11-08 |
Epicentrx, Inc. |
Oncolytic adenovirus formulation
|
|
EP3630959A4
(en)
|
2017-05-24 |
2021-03-17 |
EpicentRx, Inc. |
ANTI-ANGIOGENIC ADENOVIRUS
|
|
EP3641814A4
(en)
|
2017-06-19 |
2021-06-23 |
Medicenna Therapeutics Inc. |
USES AND METHODS FOR IL-2 SUPERAGONISTS AND AGONISTS AND FUSIONS THEREOF
|
|
WO2019016756A1
(en)
|
2017-07-21 |
2019-01-24 |
Glaxosmithkline Biologicals Sa |
ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES
|
|
SI3460052T1
(sl)
|
2017-09-20 |
2020-03-31 |
Immunicum Ab |
Izboljšane alogene dendritične celice za uporabo pri zdravljenju raka
|
|
WO2019073059A1
(en)
|
2017-10-12 |
2019-04-18 |
Freeline Therapeutics Limited |
ADENOVIRAL AUXILIARY VIRUSES WITH DEFECTIVE CYCLE LIFE, PRODUCTION AND USE FOR THE PRODUCTION OF RAAV
|
|
US11236361B2
(en)
|
2017-10-31 |
2022-02-01 |
Janssen Vaccines & Prevention B.V. |
Adenovirus and uses thereof
|
|
AU2018359492B2
(en)
|
2017-10-31 |
2023-12-14 |
Janssen Vaccines & Prevention B.V. |
Adenovirus and uses thereof
|
|
EP3704256A1
(en)
|
2017-10-31 |
2020-09-09 |
Janssen Vaccines & Prevention B.V. |
Adenovirus vectors and uses thereof
|
|
MX2020004487A
(es)
|
2017-10-31 |
2020-08-13 |
Janssen Vaccines & Prevention Bv |
Adenovirus y usos de estos.
|
|
GB201802539D0
(en)
|
2018-02-16 |
2018-04-04 |
Univ College Cardiff Consultants Ltd |
Modified adenoviruses
|
|
GB201804468D0
(en)
|
2018-03-21 |
2018-05-02 |
Valo Therapeutics Oy |
PeptiCRAd Cancer Therapy
|
|
GB201804473D0
(en)
|
2018-03-21 |
2018-05-02 |
Valo Therapeutics Oy |
Modified oncolytic adenoviruses
|
|
EP3773649A4
(en)
|
2018-03-28 |
2022-02-23 |
EpicentRx, Inc. |
PERSONALIZED CANCER VACCINE
|
|
BR112020019942A2
(pt)
|
2018-04-09 |
2021-01-26 |
Salk Institute For Biological Studies |
composições de adenovírus oncolítico com propriedades de replicação aprimoradas
|
|
WO2019202118A1
(en)
|
2018-04-20 |
2019-10-24 |
Baylor College Of Medicine |
Oncolytic virotherapy and immunotherapy
|
|
CN112638936A
(zh)
|
2018-06-12 |
2021-04-09 |
葛兰素史密丝克莱恩生物有限公司 |
腺病毒多核苷酸和多肽
|
|
WO2020014539A1
(en)
|
2018-07-11 |
2020-01-16 |
Epicentrx, Inc. |
Methods and compositions for targeting cancer cells for treatment
|
|
WO2020046130A1
(en)
|
2018-08-31 |
2020-03-05 |
Orca Therapeutics B.V. |
Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (gsk3) and methods of killing aberrant cells
|
|
JP7384457B2
(ja)
|
2018-10-09 |
2023-11-21 |
ナイキジェン，リミテッド |
ウイルスベクターを調製するための組成物および方法
|